Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized by progressive loss of motor neurons. It is also known as Lou Gehrig’s disease, named after the legendary American baseball player. More than 400,000 people have been estimated to have the disease worldwide. Perhaps the most noteworthy case of ALS is Stephen Hawking, the renowned British physicist who passed away in 2018.
ALS is fatal, progressing rapidly to attack the motor nerve cells of the brain and spinal cord to destroy muscular movements of the human body. The disease is commonly diagnosed in people between the ages of 50 and 70, and is rarely transmitted through inheritance. Most ALS cases are sporadic.
ALS leads to paralysis of voluntary muscles and eventual respiration failure. Even though the disease attacks the nerve cells of the brain, the patient’s emotional and intelligence quotient remains unaffected. ALS is caused by myriad factors, including gene mutation, immune system abnormalities, and chemical imbalance.
Signs and symptoms of ALS appear gradually. The patient may start to experience tingling feelings in his hand making it difficult to grip things, or his voice may begin to slur. Each ALS case is different, and the early symptoms may vary widely.
Some common initial symptoms include:
As ALS advances and nerve cells are destroyed, muscles progressively weaken. Eventually, it affects the ability to chew, swallow, speak and breathe.
There are traditional lines of therapies available for ALS. However, they have only been helpful in controlling the symptoms and preventing unnecessary complications, to make living with the disease more manageable.
There are multidisciplinary teams of health care professionals, including pharmacists, physicians, therapists (physical, occupational and speech), social workers, and many more who help in providing the best possible supportive care. These teams assist in designing an individualized treatment plan and provide special equipment that aims to keep patient as comfortable, mobile and independent as possible.
GIOSTAR (Global Institute of Stem Cell Therapy and Research) is home to the top experts in the field of stem cell research, and provides scientific know-how to GIOSTAR-CHICAGO. GIOSTAR-CHICAGO is an independently run facility from GIOSTAR. Involved in the field of stem cell research for almost two decades in the U.S.A, GIOSTAR has provided treatments to thousands of patients using their advanced protocols outside of the United States. GIOSTAR believes in the potential of supplementing traditional treatments for ALS (such as behavioral therapies and medications) with cellular rejuvenation therapy. Focusing solely on one particular form of treatment does not necessarily yield the desired results.
GIOSTAR opened the world’s first stem cell therapy hospital in India, and has plans to continue building stem cell treatment centers with health care partners around the world. Their goal is to develop treatments for several diseases, and offer hope to millions suffering around the globe with safe, effective and affordable healthcare.
Within the body, there are different sources of stem cells - known as the "mother" or "master" cells capable of differentiating into virtually any type of cell. It has been documented by several scientific publications that stem cells may differentiate into a specific cell or tissue type. This suggests the possibility to develop the treatment for ALS.
Some ALS patients have shared the positive results they experienced after undergoing stem cell therapy:
"After a few sessions, the improvement in my quality of life was evident, and the reports also showed this improvement. Now, I am satisfied with my decision of undergoing Stem Cell Therapy, especially at GIOSTAR, and have high hopes for my fast recovery." says Mr. Moreira.
"GIOSTAR is a real star for me, as here my friend got the best treatment, with the best techniques and the best technologies all under one roof." says Mr. May, a close friend of an ALS patient.